カテゴリ： 世界, 医療/バイオ, Market Monitor Global

豚生殖呼吸器症候群（PRRS）ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、死菌ワクチン

■ 英語タイトル：Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8583）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8583
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：111
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[豚生殖呼吸器症候群（PRRS）ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、死菌ワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の豚生殖呼吸器症候群（PRRS）ワクチン市場規模と予測を収録しています。・世界の豚生殖呼吸器症候群（PRRS）ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の豚生殖呼吸器症候群（PRRS）ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の豚生殖呼吸器症候群（PRRS）ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

豚生殖呼吸器症候群（PRRS）ワクチンのグローバル主要企業は、CAHIC、 Merial、 MSD Animal Health、 Chopper Biology、 Ceva、 ChengDu Tecbond、 Veterinary、 Ringpu Biology、 Qilu Animal、 DHN、 CAVAC、 Komipharm、 Agrovet、 Bioveta、 Jinyu Bio-Technology、 Institutul Pasteur、 MVP、 Tecon、 Zoetisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、豚生殖呼吸器症候群（PRRS）ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の豚生殖呼吸器症候群（PRRS）ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の豚生殖呼吸器症候群（PRRS）ワクチン市場：タイプ別市場シェア、2022年
・生ワクチン、死菌ワクチン

世界の豚生殖呼吸器症候群（PRRS）ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の豚生殖呼吸器症候群（PRRS）ワクチン市場：用途別市場シェア、2022年
・政府入札、市場売却

世界の豚生殖呼吸器症候群（PRRS）ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の豚生殖呼吸器症候群（PRRS）ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における豚生殖呼吸器症候群（PRRS）ワクチンのグローバル売上、2018年-2023年
・主要企業における豚生殖呼吸器症候群（PRRS）ワクチンのグローバル売上シェア、2022年
・主要企業における豚生殖呼吸器症候群（PRRS）ワクチンのグローバル販売量、2018年-2023年
・主要企業における豚生殖呼吸器症候群（PRRS）ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
CAHIC、 Merial、 MSD Animal Health、 Chopper Biology、 Ceva、 ChengDu Tecbond、 Veterinary、 Ringpu Biology、 Qilu Animal、 DHN、 CAVAC、 Komipharm、 Agrovet、 Bioveta、 Jinyu Bio-Technology、 Institutul Pasteur、 MVP、 Tecon、 Zoetis

*************************************************************

・調査・分析レポートの概要
豚生殖呼吸器症候群（PRRS）ワクチン市場の定義
市場セグメント
世界の豚生殖呼吸器症候群（PRRS）ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の豚生殖呼吸器症候群（PRRS）ワクチン市場規模
世界の豚生殖呼吸器症候群（PRRS）ワクチン市場規模：2022年 VS 2029年
世界の豚生殖呼吸器症候群（PRRS）ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの豚生殖呼吸器症候群（PRRS）ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の豚生殖呼吸器症候群（PRRS）ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：生ワクチン、死菌ワクチン
豚生殖呼吸器症候群（PRRS）ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：政府入札、市場売却
豚生殖呼吸器症候群（PRRS）ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別豚生殖呼吸器症候群（PRRS）ワクチン市場規模 2022年と2029年
地域別豚生殖呼吸器症候群（PRRS）ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
CAHIC、 Merial、 MSD Animal Health、 Chopper Biology、 Ceva、 ChengDu Tecbond、 Veterinary、 Ringpu Biology、 Qilu Animal、 DHN、 CAVAC、 Komipharm、 Agrovet、 Bioveta、 Jinyu Bio-Technology、 Institutul Pasteur、 MVP、 Tecon、 Zoetis
...

There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.
This report aims to provide a comprehensive presentation of the global market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines. This report contains market size and forecasts of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in global, including the following market information:
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines companies in 2022 (%)
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Live Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines include CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segment Percentages, by Type, 2022 (%)
Live Vaccines
Killed Vaccines
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segment Percentages, by Application, 2022 (%)
Government Tender
Market Sales
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines revenues share in global market, 2022 (%)
Key companies Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, market overview.
Chapter 2: Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Overall Market Size
2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size: 2022 VS 2029
2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players in Global Market
3.2 Top Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Companies Ranked by Revenue
3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Companies
3.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Companies
3.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Markets, 2022 & 2029
4.1.2 Live Vaccines
4.1.3 Killed Vaccines
4.2 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue & Forecasts
4.2.1 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2018-2023
4.2.2 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2024-2029
4.2.3 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share, 2018-2029
4.3 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales & Forecasts
4.3.1 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2018-2023
4.3.2 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2024-2029
4.3.3 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share, 2018-2029
4.4 By Type – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2022 & 2029
5.1.2 Government Tender
5.1.3 Market Sales
5.2 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue & Forecasts
5.2.1 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2018-2023
5.2.2 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2024-2029
5.2.3 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share, 2018-2029
5.3 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales & Forecasts
5.3.1 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2018-2023
5.3.2 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2024-2029
5.3.3 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share, 2018-2029
5.4 By Application – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2022 & 2029
6.2 By Region – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue & Forecasts
6.2.1 By Region – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2018-2023
6.2.2 By Region – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2024-2029
6.2.3 By Region – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share, 2018-2029
6.3 By Region – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales & Forecasts
6.3.1 By Region – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2018-2023
6.3.2 By Region – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2024-2029
6.3.3 By Region – Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2018-2029
6.4.2 By Country – North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2018-2029
6.4.3 US Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.4.4 Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.4.5 Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2018-2029
6.5.2 By Country – Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2018-2029
6.5.3 Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.5.4 France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.5.5 U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.5.6 Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.5.7 Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.5.9 Benelux Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2018-2029
6.6.2 By Region – Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2018-2029
6.6.3 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.6.4 Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.6.5 South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.6.7 India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2018-2029
6.7.2 By Country – South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2018-2029
6.7.3 Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.7.4 Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, 2018-2029
6.8.3 Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.8.4 Israel Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
6.8.6 UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CAHIC
7.1.1 CAHIC Company Summary
7.1.2 CAHIC Business Overview
7.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 CAHIC Key News & Latest Developments
7.2 Merial
7.2.1 Merial Company Summary
7.2.2 Merial Business Overview
7.2.3 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.2.4 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Merial Key News & Latest Developments
7.3 MSD Animal Health
7.3.1 MSD Animal Health Company Summary
7.3.2 MSD Animal Health Business Overview
7.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 MSD Animal Health Key News & Latest Developments
7.4 Chopper Biology
7.4.1 Chopper Biology Company Summary
7.4.2 Chopper Biology Business Overview
7.4.3 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.4.4 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Chopper Biology Key News & Latest Developments
7.5 Ceva
7.5.1 Ceva Company Summary
7.5.2 Ceva Business Overview
7.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Ceva Key News & Latest Developments
7.6 ChengDu Tecbond
7.6.1 ChengDu Tecbond Company Summary
7.6.2 ChengDu Tecbond Business Overview
7.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 ChengDu Tecbond Key News & Latest Developments
7.7 Veterinary
7.7.1 Veterinary Company Summary
7.7.2 Veterinary Business Overview
7.7.3 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.7.4 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Veterinary Key News & Latest Developments
7.8 Ringpu Biology
7.8.1 Ringpu Biology Company Summary
7.8.2 Ringpu Biology Business Overview
7.8.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.8.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Ringpu Biology Key News & Latest Developments
7.9 Qilu Animal
7.9.1 Qilu Animal Company Summary
7.9.2 Qilu Animal Business Overview
7.9.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.9.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Qilu Animal Key News & Latest Developments
7.10 DHN
7.10.1 DHN Company Summary
7.10.2 DHN Business Overview
7.10.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.10.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 DHN Key News & Latest Developments
7.11 CAVAC
7.11.1 CAVAC Company Summary
7.11.2 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Business Overview
7.11.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.11.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 CAVAC Key News & Latest Developments
7.12 Komipharm
7.12.1 Komipharm Company Summary
7.12.2 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Business Overview
7.12.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.12.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Komipharm Key News & Latest Developments
7.13 Agrovet
7.13.1 Agrovet Company Summary
7.13.2 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Business Overview
7.13.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.13.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Agrovet Key News & Latest Developments
7.14 Bioveta
7.14.1 Bioveta Company Summary
7.14.2 Bioveta Business Overview
7.14.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.14.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Bioveta Key News & Latest Developments
7.15 Jinyu Bio-Technology
7.15.1 Jinyu Bio-Technology Company Summary
7.15.2 Jinyu Bio-Technology Business Overview
7.15.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.15.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 Jinyu Bio-Technology Key News & Latest Developments
7.16 Institutul Pasteur
7.16.1 Institutul Pasteur Company Summary
7.16.2 Institutul Pasteur Business Overview
7.16.3 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.16.4 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 Institutul Pasteur Key News & Latest Developments
7.17 MVP
7.17.1 MVP Company Summary
7.17.2 MVP Business Overview
7.17.3 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.17.4 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.17.5 MVP Key News & Latest Developments
7.18 Tecon
7.18.1 Tecon Company Summary
7.18.2 Tecon Business Overview
7.18.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.18.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.18.5 Tecon Key News & Latest Developments
7.19 Zoetis
7.19.1 Zoetis Company Summary
7.19.2 Zoetis Business Overview
7.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Product Offerings
7.19.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in Global (2018-2023)
7.19.5 Zoetis Key News & Latest Developments
8 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Capacity, Analysis
8.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Capacity, 2018-2029
8.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Supply Chain Analysis
10.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Value Chain
10.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Upstream Market
10.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ハラール栄養補助食品＆ワクチンのグローバル市場展望 2023年-2029年：ハラールサプリメント、ハラールワクチン
  • 鶏用ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン、
  • アヒル用ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活性ワクチン
  • 豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン
  • ジフテリア/破傷風/百日咳（DPT）ワクチンのグローバル市場展望 2023年-2029年：DTwP型、DTaP型
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8583 )"豚生殖呼吸器症候群（PRRS）ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、死菌ワクチン" (英文：Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。